Acylcarnitines, including in vitro loading tests

Laboratory Guide to the Methods in Biochemical Genetics

Volumn , Issue , 2008, Pages 171-206

  Matern, Dietrich ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73949114277     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-76698-8_10     Document Type: Chapter

References (67)

1. Bremer J (1983) Carnitine-metabolism and functions. Physiol Rev 63:1420-1480
2. Gulewitsch WI, Krimberg R (1905) Zur Kenntnis der Extraktivstoffe der Muskeln. II. Mitteilung. Ueber das Carnitin. Hoppe Seylers Z Physiol Chem 45:326-330
3. Tomita M, Sendju Y (1927) ?ber die Oxyaminverbindungen, welche die Biuretreaktion zeigen. III. Spaltung der gamma-Amino-beta-oxy-butters?re in die optisch-aktiven Komponenten. Hoppe Seylers Z Physiol Chem 169:263-277
4. Carter HE, Bhattacharyya PK, Weidman KR, Fraenkel G (1952) Chemical studies on vitamin BT isolation and characterization as carnitine. Arch Biochem Biophys 38:405-416
5. Bhattacharyya PK, Carter HE, Fraenkel G, Weidman KR (1952) The identity of vitamin BT with carnitine. Arch Biochem 35:241-242
6. Engel AG, Angelini C (1973) Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science 179:899-902
7. DiMauro S, DiMauro PM (1973) Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 182:929-931
8. Rinaldo P, Matern D, Bennett MJ (2002) Fatty Acid oxidation disorders. Annu Rev Physiol 64:477-502
9. Zhang J, Zhang W, Zou D, et a (2002) Cloning and functional characterization of ACAD-9, a novel member of human acyl-CoA dehydrogenase family. Biochem Biophys Res Commun 297:1033-1042
10. Ensenauer R, He M, Willard JM, et al (2005) Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids. J Biol Chem 280:32309-32316
11. Roe CR, Bohan TP (1982) L-carnitine therapy in propionicacidaemia. Lancet 1:1411-1412
12. Roe CR, Hoppel CL, Stacey TE, Chalmers RA, Tracey BM, Millington DS (1983) Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Arch Dis Child 58:916-920
13. Chalmers RA, Roe CR, Stacey TE, Hoppel CL (1988) Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. Pediatr Res 18:1325-1328
14. Millington DS, Roe CR, Maltby DA (1984) Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease. Biomed Mass Spectrom 11:236-241
15. Roe CR, Millington DS, Maltby DA, Kahler SG, Bohan TP (1984) L-carnitine therapy in isovaleric acidemia. J Clin Invest 74:2290-2295
16. Roe CR, Millington DS, Maltby DA, Bohan TP, Hoppel CL (1984) L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J Clin Invest 73:1785-1788
17. Millington DS, Terada N, Chace DH, et al (1992) The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. Prog Clin Biol Res 375:339-354
18. Pitt JJ, Eggington M, Kahler SG (2002) Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clin Chem 48:1970-1980
19. Tortorelli S, Hahn SH, Cowan TM, Brewster TG, Rinaldo P, Matern D (2005) The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I. Mol Genet Metab 84:137-143
20. Ensenauer R, Vockley J, Willard JM, et al (2004) A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet 75:1136-1142
21. Oglesbee D, He M, Majumder N, et al (2007) Development of a newborn screening follow-up algorithm for the diagnosis of isobutyryl-CoA dehydrogenase deficiency. Genet Med 9:108-116
22. Millington DS, Kodo N, Norwood DL, Roe CR (1990) Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 13:321-324
23. Rinaldo P, Hahn S, Matern D (2004) Clinical biochemical genetics in the twenty-first century. Acta Paediatr 93:22-26
24. Rinaldo P, Studinski AL, Matern D (2001) Prenatal diagnosis of disorders of fatty acid transport and mitochondrial oxidation. Prenat Diagn 21:52-54
25. Morel CF, Watkins D, Scott P, Rinaldo P, Rosenblatt DS (2005) Prenatal diagnosis for methylmalonic acidemia and inborn errors of vitamin B12 metabolism and transport. Mol Genet Metab 86:160-171
26. Braida L, Crovella S, Boniotto M, et al (2001) A rapid and quantitative mass spectrometry method for determining the concentration of acylcarnitines and amino acids in amniotic fluid. Prenat Diagn 21:543-546
27. Van Hove JL, Chace DH, Kahler SG, Millington DS (1993) Acylcarnitines in amniotic fluid: application to the prenatal diagnosis of propionic acidaemia. J Inherit Metab Dis 16:361-367
28. Nada MA, Rhead WJ, Sprecher H, Schulz H, Roe CR (1995) Evidence for intermediate channeling in mitochondrial beta-oxidation. J Biol Chem 270:530-535
29. Nada MA, Vianey-Saban C, Roe CR, et al (1996) Prenatal diagnosis of mitochondrial fatty acid oxidation defects. Prenat Diagn 16:117-124
30. Schmidt-Sommerfeld E, Bobrowski PJ, Penn D, Rhead WJ, Wanders RJA, Bennet MJ (1998) Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders. Pediatr Res 44:210-214
31. Roe CR, Roe DS (1999) Recent developments in the investigation of inherited metabolic disorders using cultured human cells. Mol Genet Metab 68:243-257
32. Ventura FV, Costa CG, Struys EA, et al (1999) Quantitative acylcarnitine profiling in fibroblasts using U-C-13 palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta281:1-17
33. Shen JJ, Matern D, Millington DS, et al (2000) Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders. J Inherit Metab Dis 23:27-44
34. Roe DS, Vianey-Saban C, Sharma S, Zabot MT, Roe CR (2001) Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype. Clin Chim Acta 312:55-67
35. Giak Sim K, Carpenter K, Hammond J, Christodoulou J, Wilcken B (2002) Quantitative fibroblast acylcarnitine profiles in mitochondrial fatty acid beta-oxidation defects: phenotype/metabolite correlations. Mol Genet Metab 76:327-334
36. Okun JG, Kolker S, Schulze A, et al (2002) A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency. Biochim Biophys Acta 1584:91-98
37. Young SP, Matern D, Gregersen N, et al (2003) A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency. Clin Chim Acta 337:103-113
38. Schulze-Bergkamen A, Okun JG, Spiekerkotter U, et al (2005) Quantitative acylcarnitine profiling in peripheral blood mononuclear cells using in vitro loading with palmitic and 2-oxoadipic acids: biochemical confirmation of fatty acid oxidation and organic acid disorders. Pediatr Res 58:873-880
39. American College of Medical Genetics. Standards and Guidelines for Clinical Genetics Laboratorie, 2005
40. Vaz FM, Wanders RJ (2002) Carnitine biosynthesis in mammals. Biochem J 361:417-429
41. Hamilton JJ, Hahn P (1987) Carnitine and carnitine esters in rat bile and human duodenal fluid. Can J Physiol Pharmacol 65:1816-1820
42. Rashed MS, Ozand PT, Bennett MJ, Barnard JJ, Govindaraju DR, Rinaldo P (1995) Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile. Clin Chem 41:1109-1114
43. Jakobs BS, Wanders RJ (1995) Fatty acid beta-oxidation in peroxisomes and mitochondria: the first, unequivocal evidence for the involvement of carnitine in shuttling propionyl-CoA from peroxisomes to mitochondria. Biochem Biophys Res Commun 213:1035-1041
44. Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J (2004) Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 25:495-520
45. Bieber LL, Choi YR (1977) Isolation and identification of aliphatic short-chain acylcarnitines from beef heart: possible role for carnitine in branched-chain amino acid metabolism. Proc Natl Acad Sci U S A 74:2795-2798
46. Costa CG, Struys EA, Bootsma A, et al (1997) Quantitative analysis of plasma acylcarnitines using gas chromatography chemical ionization mass fragmentography. J Lipid Res 38:173-182
47. Schmidt-Sommerfeld E, Penn D, Duran M, et al (1992) Detection and quantitation of acylcarnitines in plasma and blood spots from patients with inborn errors of fatty acid oxidation. Prog Clin Biol Res 375:355-362
48. Yergey AL, Liberato DJ, Millington DS (1984) Thermospray liquid chromatography/mass spectrometry for the analysis of L-carnitine and its short-chain acyl derivatives. Anal Biochem 139:278-283
49. Millington DS, Bohan TP, Roe CR, Yergey AL, Liberato DJ (1985) Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry. Clin Chim Acta 145:69-76
50. Millington DS, Maltby DA, Roe CR (1986) Rapid detection of argininosuccinic aciduria and citrullinuria by fast atom bombardment and tandem mass spectrometry. Clin Chim Acta 155:173-178
51. Millington DS, Norwood DL, Kodo N, Roe CR, Inoue F (1989) Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue. Anal Biochem 180:331-339
52. Matern D, Magera MJ (2001) Mass spectrometry methods for metabolic and health assessment. J Nutr 131:1615S-1620S
53. Heinig K, Henion J (1999) Determination of carnitine and acylcarnitines in biological samples by capillary electrophoresis-mass spectrometry. J Chromatogr B Biomed Sci Appl 735:171-188
54. Ghoshal AK, Guo T, Soukhova N, Soldin SJ (2005) Rapid measurement of plasma acylcarnitines by liquid chromatography-tandem mass spectrometry without derivatization. Clin Chim Acta 358:104-112
55. Matern D, Strauss AW, Hillman SL, Mayatepek E, Millington DS, Trefz FK (1999) Diagnosis of mitochondrial trifunctional protein deficiency in a blood spot from the newborn screening card by tandem mass spectrometry and DNA analysis. Pediatr Res 46:45-49
56. Browning MF, Larson C, Strauss A, Marsden DL (2005) Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects. J Inherit Metab Dis 28:545-550
57. Van Hove JL, Kahler SG, Feezor MD, et al (2000) Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. J Inherit Metab Dis 23:571-582
58. Koeberl DD, Young SP, Gregersen NS, et al (2003) Rare disorders of metabolism with elevated butyryl-and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening. Pediatr Res 54:219-223
59. Matern D, He M, Berry SA, et al (2003) Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. Pediatrics 112:74-78
60. Abdenur JE, Chamoles NA, Guinle AE, Schenone AB, Fuertes AN (1998) Diagnosis of isovaleric acidaemia by tandem mass spectrometry: false positive result due to pivaloylcarnitine in a newborn screening programme. J Inherit Metab Dis 21:624-630
61. Gibson KM, Bennett MJ, Naylor EW, Morton DH (1998) 3-Methylcrotonyl- coenzyme a carboxylase deficiency in amish/mennonite adults identified by detection of increased acylcarnitines in blood spots of their children. J Pediatr 132:519-523
62. Hintz SR, Matern D, Strauss A, et al (2002) Early neonatal diagnosis of long-chain 3-hydroxyacyl coenzyme a dehydrogenase and mitochondrial trifunctional protein deficiencies. Mol Genet Metab 75:120-127
63. Vianey-Saban C, Boyer S, Levrat V, et al (2004) Interference of Cefotaxime in plasma acylcarnitine profile mimicking an increase of 3-hydroxypalmitoleylcarnitine (C16:1-OH) using butyl esters. J Inherit Metab Dis 27:94
64. Malvagia S, la Marca G, Casetta B, et al (2006) Falsely elevated C4-carnitine as expression of glutamate formiminotransferase deficiency in tandem mass spectrometry newborn screening. J Mass Spectrom 41:263-265
65. Roe DS, Yang BZ, Vianey-Saban C, Struys E, Sweetman L, Roe CR (2006) Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts. Mol Genet Metab 87:40-47
66. Carrozzo R, Dionisi-Vici C, Steuerwald U, et al. (2007) SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 130(Pt 3):862-74.
67. Roe CR, Sweetman L, Roe DS, David F, Brunengraber H (2002) Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 110:259-269